Tumor suppressor protein (p)53, is a regulator of NF-κ;B repression by the glucocorticoid receptor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 41, 2011, Pages 17117-17122

  Murphy, Samantha H ^a,b   Suzuki, Kotaro ^a,d   Downes, Michael ^a   Welch, Genevieve L ^c   De Jesus, Paul ^c,e   Miraglia, Loren J ^c   Orth, Anthony P ^c   Chanda, Sumit K ^c,e   Evans, Ronald M ^a   Verma, Inder M ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^d CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; SHOCK; SIGNAL TRANSDUCTION;

ANIMALS; DEXAMETHASONE; HIGH-THROUGHPUT SCREENING ASSAYS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PROTEIN INTERACTION MAPS; RECEPTORS, GLUCOCORTICOID; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80054761315     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1114420108     Document Type: Article

References (45)

1. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725-734.
2. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S (1995) Rel/NF-κ; B/I κ; B family: Intimate tales of association and dissociation. Genes Dev 9:2723-2735. (Pubitemid 3009952)
3. Ghosh S, May MJ, Kopp EB (1998) NF-κ; B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260. (Pubitemid 28183365)
4. Baeuerle PA, Henkel T (1994) Function and activation of NF-κ; B in the immune system. Annu Rev Immunol 12:141-179.
5. Thanos D, Maniatis T (1995) NF-κ; B: A lesson in family values. Cell 80:529-532.
6. Mercurio F, et al. (1997) IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278:860-866. (Pubitemid 27467923)
7. Spencer E, Jiang J, Chen ZJ (1999) Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP. Genes Dev 13:284-294. (Pubitemid 29095800)
8. Zhong H, Voll RE, Ghosh S (1998) Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1:661-671. (Pubitemid 128379244)
9. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G (2003) Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 22:1313-1324. (Pubitemid 36362695)
10. Duran A, Diaz-Meco MT, Moscat J (2003) Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J 22:3910-3918. (Pubitemid 36975717)
11. Pratt WB, Toft DO (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18:306-360. (Pubitemid 27246880)
12. Dittmar KD, Demady DR, Stancato LF, Krishna P, Pratt WB (1997) Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. The role of p23 is to stabilize receptor.hsp90 heterocomplexes formed by hsp90.p60.hsp70. J Biol Chem 272:21213-21220. (Pubitemid 27373984)
13. Davies TH, Ning YM, Sánchez ER (2002) A new first step in activation of steroid receptors: Hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem 277:4597-4600. (Pubitemid 34968486)
14. Schoneveld OJ, Gaemers IC, Lamers WH (2004) Mechanisms of glucocorticoid signalling. Biochim Biophys Acta 1680:114-128. (Pubitemid 39361130)
15. Schaaf MJ, Cidlowski JA (2002) Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 83:37-48. (Pubitemid 37040640)
16. McKay LI, Cidlowski JA (1999) Molecular control of immune/inflammatory responses: Interactions between nuclear factor-κ; B and steroid receptor-signaling pathways. Endocr Rev 20:435-459. (Pubitemid 30648895)
17. Reichardt HM, Schütz G (1998) Glucocorticoid signalling - multiple variations of a common theme. Mol Cell Endocrinol 146:1-6. (Pubitemid 29003274)
18. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE (1993)Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates. Ann Intern Med 119:1198-1208. (Pubitemid 23361450)
19. Funder JW (1997) Glucocorticoid and mineralocorticoid receptors: Biology and clinical relevance. Annu Rev Med 48:231-240.
20. Neeck G (2002) Fifty years of experience with cortisone therapy in the study and treatment of rheumatoid arthritis. Ann N Y Acad Sci 966:28-38.
21. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS, Jr. (1995) Role of transcriptional activation of I κ; B α in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
22. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: Inhibition of NF-κ; B activity through induction of I κ; B synthesis. Science 270:286-290.
23. Horwitz KB, et al. (1996) Nuclear receptor coactivators and corepressors. Mol Endocrinol 10:1167-1177. (Pubitemid 26330950)
24. Gerritsen ME, et al. (1997) CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 94:2927-2932. (Pubitemid 27157241)
25. McKay LI, Cidlowski JA (2000) CBP (CREB binding protein) integrates NF-κ;B and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol 14: 1222-1234. (Pubitemid 32260483)
26. Xu W, et al. (2001) A transcriptional switch mediated by cofactor methylation. Science 294:2507-2511. (Pubitemid 34027283)
27. Ray A, Prefontaine KE (1994) Physical association and functional antagonism between the p65 subunit of transcription factor NF-κ; B and the glucocorticoid receptor. Proc Natl Acad Sci USA 91:752-756. (Pubitemid 24041480)
28. König R, et al. (2007) A probability-based approach for the analysis of large-scale RNAi screens. Nat Methods 4:847-849. (Pubitemid 350055583)
29. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
30. Vassilev LT, et al. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303:844-848. (Pubitemid 38174664)
31. Yang N, Zhang W, Shi XM (2008) Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression. J Cell Biochem 103:1760-1771. (Pubitemid 351501908)
32. Di Marco B, et al. (2007) Glucocorticoid-induced leucine zipper (GILZ)/NF-kappaB interaction: Role of GILZ homo-dimerization and C-terminal domain. Nucleic Acids Res 35:517-528. (Pubitemid 46232068)
33. Zhang L, Nie L, Maki CG (2006) P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity. Mol Cancer 5:68.
34. Suehiro T, et al. (2004) Regulation of human glucocorticoid receptor gene transcription by Sp1 and p53. Mol Cell Endocrinol 222:33-40. (Pubitemid 38900813)
35. Sengupta S, Vonesch JL, Waltzinger C, Zheng H, Wasylyk B (2000) Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells. EMBO J 19:6051-6064.
36. Sengupta S, Wasylyk B (2001) Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. Genes Dev 15:2367-2380. (Pubitemid 32899741)
37. Maiyar AC, Phu PT, Huang AJ, Firestone GL (1997) Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein. Mol Endocrinol 11:312-329. (Pubitemid 27106327)
38. Urban G, et al. (2003) Identification of a functional link for the p53 tumor suppressor protein in dexamethasone-induced growth suppression. J Biol Chem 278:9747-9753. (Pubitemid 36800473)
39. Crochemore C, Michaelidis TM, Fischer D, Loeffler JP, Almeida OF (2002) Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation. FASEB J 16:761-770. (Pubitemid 34615124)
40. Maas K, Westfall M, Pietenpol J, Olsen NJ, Aune T (2005) Reduced p53 in peripheral blood mononuclear cells from patients with rheumatoid arthritis is associated with loss of radiation-induced apoptosis. Arthritis Rheum 52:1047-1057. (Pubitemid 40530110)
41. Yamanishi Y, et al. (2005) p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritis. Arthritis Res Ther 7:R12-R18.
42. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307-310.
43. Vousden KH, Lu X (2002) Live or let die: The cell's response to p53. Nat Rev Cancer 2: 594-604. (Pubitemid 37328926)
44. Viatour P, Merville MP, Bours V, Chariot A (2005) Phosphorylation of NF-kappaB and IkappaB proteins: Implications in cancer and inflammation. Trends BiochemSci 30:43-52. (Pubitemid 40093740)
45. Clevers H (2004) At the crossroads of inflammation and cancer. Cell 118:671-674.